| Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C S Petta, C Cammā, C Scazzone, C Tripodo, V Di Marco, A Bono, D Cabibi, ... Hepatology 51 (4), 1158-1167, 2010 | 558 | 2010 |
| Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015 | 557 | 2015 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 449 | 2018 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology 54 (6), 2055-2063, 2011 | 418 | 2011 |
| Update of the statements on biology and clinical impact of occult hepatitis B virus infection G Raimondo, S Locarnini, T Pollicino, M Levrero, F Zoulim, AS Lok, ... Journal of hepatology 71 (2), 397-408, 2019 | 410 | 2019 |
| The long-term course of chronic hepatitis B V Di Marco, OL Iacono, C Cammā, A Vaccaro, M Giunta, G Martorana, ... Hepatology 30 (1), 257-264, 1999 | 339 | 1999 |
| Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine DV Di Marco, A Marzano, P Lampertico, P Andreone, T Santantonio, ... Hepatology 40 (4), 883-891, 2004 | 330 | 2004 |
| Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents V Calvaruso, G Cabibbo, I Cacciola, S Petta, S Madonia, A Bellia, F Tinč, ... Gastroenterology 155 (2), 411-421. e4, 2018 | 325 | 2018 |
| Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication AJ van der Meer, JJ Feld, H Hofer, PL Almasio, V Calvaruso, ... Journal of hepatology 66 (3), 485-493, 2017 | 290 | 2017 |
| Prophylaxis and treatment of hepatitis B in immunocompromised patients A Marzano, E Angelucci, P Andreone, M Brunetto, R Bruno, P Burra, ... Digestive and Liver Disease 39 (5), 397-408, 2007 | 283 | 2007 |
| Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C L Rizzo, V Calvaruso, B Cacopardo, N Alessi, M Attanasio, S Petta, ... Official journal of the American College of Gastroenterology| ACG 106 (12 …, 2011 | 278 | 2011 |
| Hepatitis C viremia in chronic liver disease: relationship to interferon-α or corticosteroid treatment S Magrin, A Craxi, C Fabiano, RG Simonetti, G Fiorentino, L Marino, ... Hepatology 19 (2), 273-279, 1994 | 264 | 1994 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 246 | 2019 |
| The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease S Petta, M Maida, FS Macaluso, V Di Marco, C Cammā, D Cabibi, A Craxė Hepatology 62 (4), 1101-1110, 2015 | 237 | 2015 |
| SAFE biopsy: a validated method for large‐scale staging of liver fibrosis in chronic hepatitis C G Sebastiani, P Halfon, L Castera, S Pol, DL Thomas, A Mangia, ... Hepatology 49 (6), 1821-1827, 2009 | 232 | 2009 |
| Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation … S Petta, VWS Wong, C Cammā, JB Hiriart, GLH Wong, F Marra, J Vergniol, ... Hepatology 65 (4), 1145-1155, 2017 | 217 | 2017 |
| Sarcopenia is associated with severe liver fibrosis in patients with non‐alcoholic fatty liver disease S Petta, S Ciminnisi, V Di Marco, D Cabibi, C Cammā, A Licata, ... Alimentary pharmacology & therapeutics 45 (4), 510-518, 2017 | 216 | 2017 |
| Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection S Petta, C Camma, V Di Marco, N Alessi, D Cabibi, R Caldarella, A Licata, ... Official journal of the American College of Gastroenterology| ACG 103 (5 …, 2008 | 215 | 2008 |
| Hyperuricemia is associated with histological liver damage in patients with non‐alcoholic fatty liver disease S Petta, C Cammā, D Cabibi, V Di Marco, A Craxė Alimentary pharmacology & therapeutics 34 (7), 757-766, 2011 | 213 | 2011 |
| Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C C Cammā, S Bruno, V Di Marco, D Di Bona, M Rumi, M Vinci, C Rebucci, ... Hepatology 43 (1), 64-71, 2006 | 211 | 2006 |
